FDA Proposes Permanent Ban on Compounded Semaglutide and Tirzepatide On April 30, 2026, the FDA proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, effectively ending large-scale compounding of GLP-1 drugs
However, inadequate protein intake leads to muscle loss during weight loss, and muscle loss directly impacts energy levels
For instance, a study published in 2022 indicated that semaglutide could reduce levels of C-reactive protein, a marker of inflammation, suggesting a potential protective effect against inflammation-related conditions
If you miss a dose of Ozempic, inject the drug as soon as you remember
Here is the math, broken down for every common concentration you will encounter with compounded semaglutide
Because of this, Ozempic has become one of the most commonly prescribed drugs in the country, with nearly 5 million prescriptions in 2020